A somatostatin analogue inhibits MAP kinase activation and cell proliferation in human neuroblastoma and in human small cell lung carcinoma cell lines

FEBS Letters

Volumn 397, Issue 2-3, 1996, Pages 164-168

  Cattaneo, M G ^a   Amoroso, D ^a   Gussoni, G ^b   Sanguini, A M ^b   Vicentini, L M ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IPSEN   (France)

Author keywords

MAP kinase; Proliferation; Somatostatin

Indexed keywords

ANGIOPEPTIN; CALCIUM; CARBACHOL; MITOGEN ACTIVATED PROTEIN KINASE; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM; CARBACHOL; CARCINOMA, SMALL CELL; CELL DIVISION; CYCLIC AMP; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; HYDROGEN-ION CONCENTRATION; INSULIN-LIKE GROWTH FACTOR I; LUNG NEOPLASMS; NEUROBLASTOMA; PEPTIDES, CYCLIC; SIGNAL TRANSDUCTION; SOMATOSTATIN; TUMOR CELLS, CULTURED;

EID: 0030592830     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(96)01159-3     Document Type: Article

References (24)

1. [1] Reichlin, S. (1983) New Engl. J. Med. 309, 1495-1501.
2. [2] Reichlin, S. (1983) New Engl. J. Med. 309, 1556-1563.
3. [3] Reubi, J.-C. and Laissue, J.A. (1995) Trends Pharmacol. Sci. 16, 110-115.
4. [4] Reisine, T. and Bell, G.I. (1995) Endocr. Rev. 16, 427-442.
5. [5] Robinson, C. and Castañer, J. (1994) Drugs Future 19, 992-999.
6. [6] Seger, R., Seger, D., Reszka, A.A., Munar, E.S., Eldar-Finkelman, H., Dobrowolska, G., Jensen, A.M., Campbell, J.S., Fisher, E.H. and Krebs, E.G. (1994) J. Biol. Chem. 269, 25699-25709.
7. [7] Salomon, Y. (1979) in: Advances in Cyclic Nucleotide Research (Brooker G., Greengard, P. and Robinson, G.A., Eds.), Vol. 10, pp. 35-55. Raven Press, New York.
8. [8] Cattaneo, M.G., Palazzi, E., Bondiolotti, G. and Vicentini, L.M. (1994) Eur. J. Pharmacol. 268, 425-430.
9. [9] Pandiella, A., Malgaroli, A., Meldolesi, J. and Vicentini, L.M. (1987) Exp. Cell Res. 170, 603-614.
10. [10] Lambert, D.G. and Nahorski, S.R. (1990) Biochem. J. 265, 555-562.
11. [11] Spada, A., Reza-Elahi, F., Lania, A., Bassetti, M. and Atti, E. (1990) J. Clin. Endocrinol. Metab. 70, 1262-1268.
12. [12] Kleuss, C., Hescheler, J., Ewel, C., Rosenthal, W., Schultz, G. and Witting, R. (1991) Nature 353, 43-48.
13. [13] Codignola, A., Tarroni, P., Clementi, F., Polio, A., Lovallo, M., Carbone, E. and Sher, E. (1993) J. Biol. Chem. 268, 26240-26247.
14. [14] Vaughan, P.F., Kaye, D.F., Reeve, H.L., Ball, S.G. and Peers, C. (1993) J. Neurochem, 60, 2159-2166.
15. [15] Moody, T.W. and Cuttitta, F. (1993) Life Sci. 52, 1161-1173.
16. [16] Martin, D.M., Singleton, J.R., Meghani, M.A. and Feldman, E.L. (1993) Regul. Peptides 48, 225-232.
17. [17] Rosen, L.B., Ginty, D.D., Weber. M.J. and Greenberg, M.E. (1994) Neuron 12, 1207-1221.
18. [18] Barber, D.L., McGuire, M.E. and Ganz, M.B. (1989) J. Biol. Chem. 264, 21038-21042.
19. [19] O'Byrne, K.J. and Carney, D.N. (1993) Lung Cancer 10, 151-172.
20. [20] Seger, R. and Krebs, E.G. (1995) FASEB J. 9, 726-735.
21. [21] Cattaneo, M.G., Gullo, M. and Vicentini, L.M. (1993) Eur. J. Pharmacol. 247, 325-331.
22. [22] Vicentini, L.M. and Villereal, M.L. (1986) Life Sci. 38, 2269-2276.
23. [23] Pan, G., Florio, T. and Stork, P.J. (1992) Science 256, 1215-1217.
24. [24] Zeggari, M., Esteve, J.-P., Rauly, I., Cambillau, C., Mazarguil, H., Dufresne, M., Pradayrol, L., Chayvialle, J.-A., Vaysse, N. and Susini, C. (1994) Biochem. J. 303, 441-448.